VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,492 | -10.6% | 650 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $19,572 | -6.9% | 650 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $21,028 | -24.5% | 650 | -33.1% | 0.00% | -25.0% |
Q4 2022 | $27,858 | +21.1% | 972 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $23,000 | -14.8% | 972 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $27,000 | -27.0% | 972 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $37,000 | +19.4% | 972 | 0.0% | 0.01% | +20.0% |
Q4 2021 | $31,000 | -51.6% | 972 | -55.3% | 0.01% | -54.5% |
Q3 2021 | $64,000 | -42.3% | 2,176 | -33.6% | 0.01% | -42.1% |
Q2 2021 | $111,000 | +73.4% | 3,276 | +65.8% | 0.02% | +46.2% |
Q1 2021 | $64,000 | +48.8% | 1,976 | +64.1% | 0.01% | +44.4% |
Q4 2020 | $43,000 | +87.0% | 1,204 | +100.7% | 0.01% | +50.0% |
Q3 2020 | $23,000 | – | 600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $21,165,410 | 69.82% |
New Harbor Financial Group, LLC | 1,523,632 | $43,667,279 | 18.06% |
Cadence Wealth Management LLC | 617,285 | $17,691,382 | 15.17% |
Windmill Hill Asset Management Ltd | 798,150 | $22,874,979 | 14.71% |
Slate Path Capital LP | 8,755,000 | $250,918,300 | 13.50% |
SPX Gestao de Recursos Ltda | 3,997,000 | $114,554,020 | 12.37% |
New Harbor Financial Group, LLC | 704,500 | $20,190,970 | 8.35% |
Eschler Asset Management LLP | 150,000 | $4,299,000 | 8.15% |
Hollow Brook Wealth Management LLC | 527,007 | $15,104,021 | 7.23% |
Yong Rong (HK) Asset Management Ltd | 400,000 | $11,464 | 7.22% |